Duflot_2019_Cardiovasc.Diabetol_18_35

Reference

Title : Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients - Duflot_2019_Cardiovasc.Diabetol_18_35
Author(s) : Duflot T , Moreau-Grange L , Roche C , Iacob M , Wils J , Remy-Jouet I , Cailleux AF , Leuillier M , Renet S , Li D , Morisseau C , Lamoureux F , Richard V , Prevost G , Joannides R , Bellien J
Ref : Cardiovasc Diabetol , 18 :35 , 2019
Abstract : Duflot_2019_Cardiovasc.Diabetol_18_35
ESTHER : Duflot_2019_Cardiovasc.Diabetol_18_35
PubMedSearch : Duflot_2019_Cardiovasc.Diabetol_18_35
PubMedID: 30885203

Related information

Citations formats

Duflot T, Moreau-Grange L, Roche C, Iacob M, Wils J, Remy-Jouet I, Cailleux AF, Leuillier M, Renet S, Li D, Morisseau C, Lamoureux F, Richard V, Prevost G, Joannides R, Bellien J (2019)
Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients
Cardiovasc Diabetol 18 :35

Duflot T, Moreau-Grange L, Roche C, Iacob M, Wils J, Remy-Jouet I, Cailleux AF, Leuillier M, Renet S, Li D, Morisseau C, Lamoureux F, Richard V, Prevost G, Joannides R, Bellien J (2019)
Cardiovasc Diabetol 18 :35